Management Board ǀ Apogenix

Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.

Apogee DA-16-X

Maximizing Board Effectiveness - Tenth Power Publishing

Rapport API Management & Platform 2022 Gartner

Clinical Candidates ǀ Apogenix

Volunteer Board Management Software - BoardSpace

Metadata Management Tool- Metadata Automation Platform-ApoGI

Pingboard on X: 's entire executive org chart as they plan for the new year. Thanks to @eugenekim222 at @CNBCtech for the article: Click here to view > Build your own

Terraforming Mars - Ares Expedition (Collector's Edition) – The Board Gamer AU

Gene expression profiles in genome instability-based classes of colorectal cancer, BMC Cancer